ClinicalTrials.govpublic full text
Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)
leukemia, myeloid, monocytic, immunotherapy, vaccine, mds, high risk myelodysplastic syndrome, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 851063
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.